文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model.

作者信息

Tapak Leili, Hamidi Omid, Amini Payam, Afshar Saeid, Salimy Siamak, Dinu Irina

机构信息

Department of Biostatistics, School of Public Health and Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Department of Science, Hamedan University of Technology, Hamedan, Iran.

出版信息

Cancer Inform. 2023 Mar 21;22:11769351231157942. doi: 10.1177/11769351231157942. eCollection 2023.


DOI:10.1177/11769351231157942
PMID:36968522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10034277/
Abstract

BACKGROUND: Breast cancer (BC) has been reported as one of the most common cancers diagnosed in females throughout the world. Survival rate of BC patients is affected by metastasis. So, exploring its underlying mechanisms and identifying related biomarkers to monitor BC relapse/recurrence using new statistical methods is essential. This study investigated the high-dimensional gene-expression profiles of BC patients using penalized additive hazards regression models. METHODS: A publicly available dataset related to the time to metastasis in BC patients (GSE2034) was used. There was information of 22 283 genes expression profiles related to 286 BC patients. Penalized additive hazards regression models with different penalties, including LASSO, SCAD, SICA, MCP and Elastic net were used to identify metastasis related genes. RESULTS: Five regression models with penalties were applied in the additive hazards model and jointly found 9 genes including , , , , -1, , , and . According the median of the prognostic index calculated using the regression coefficients of the penalized additive hazards model, the patients were labeled as high/low risk groups. A significant difference was detected in the survival curves of the identified groups. The selected genes were examined using validation data and were significantly associated with the hazard of metastasis. CONCLUSION: This study showed that , -1, , , and are the potential recurrence and metastatic predictors in breast cancer and can be taken into account as candidates for further research in tumorigenesis, invasion, metastasis, and epithelial-mesenchymal transition of breast cancer.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/10034277/d90f7f77a47c/10.1177_11769351231157942-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/10034277/4af062818802/10.1177_11769351231157942-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/10034277/d90f7f77a47c/10.1177_11769351231157942-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/10034277/4af062818802/10.1177_11769351231157942-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/10034277/d90f7f77a47c/10.1177_11769351231157942-fig2.jpg

相似文献

[1]
Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model.

Cancer Inform. 2023-3-21

[2]
A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.

Medicine (Baltimore). 2020-4

[3]
Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.

JAMA Netw Open. 2020-10-1

[4]
Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples.

Gland Surg. 2021-3

[5]
Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.

Front Genet. 2020-4-24

[6]
Application of additive hazards models for analyzing survival of breast cancer patients.

J Res Med Sci. 2020-10-28

[7]
Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.

BMC Med Res Methodol. 2017-5-22

[8]
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.

Lancet Oncol. 2020-11

[9]
Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.

Biochem Biophys Rep. 2022-1-10

[10]
Identification of potential prognostic markers associated with lung metastasis in breast cancer by weighted gene co-expression network analysis.

Cancer Biomark. 2022

引用本文的文献

[1]
Nucleolar proteomics identifies S100A16 as a key nucleolar protein driving breast cancer metastasis.

Cell Death Dis. 2025-8-22

[2]
Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target.

Front Cell Dev Biol. 2024-11-5

本文引用的文献

[1]
Maximum likelihood estimation in the additive hazards model.

Biometrics. 2023-9

[2]
Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity.

Nat Cancer. 2022-6

[3]
CD44: A Multifunctional Mediator of Cancer Progression.

Biomolecules. 2021-12-9

[4]
Public transcriptome database-based selection and validation of reliable reference genes for breast cancer research.

Biomed Eng Online. 2021-12-11

[5]
Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.

Blood Cancer J. 2021-12-4

[6]
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.

Neoplasia. 2021-12

[7]
A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.

Front Oncol. 2021-9-16

[8]
Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis.

Front Cell Dev Biol. 2021-5-24

[9]
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer.

BMC Womens Health. 2021-5-29

[10]
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer.

Cancer Cell Int. 2021-2-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索